These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 8983800
61. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB. Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778 [Abstract] [Full Text] [Related]
62. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome. Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A. Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815 [Abstract] [Full Text] [Related]
63. [Advances in the treatment of adult nephrotic syndrome]. Yokoyama H, Asaka M, Yamaya H, Wada T. Nihon Jinzo Gakkai Shi; 2007 Nov; 49(2):108-12. PubMed ID: 17375618 [No Abstract] [Full Text] [Related]
64. Renal histological findings in adults in Jamaica. Soyibo AK, Shah D, Barton EN, Williams W, Smith R. West Indian Med J; 2009 Jun; 58(3):265-9. PubMed ID: 20043536 [Abstract] [Full Text] [Related]
65. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A, RITERM study group. Autoimmun Rev; 2020 Nov; 19(11):102671. PubMed ID: 32942039 [Abstract] [Full Text] [Related]
66. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P. Am J Med; 1987 May; 82(5):938-44. PubMed ID: 3578362 [Abstract] [Full Text] [Related]
70. Our experience in the combined pathogenetic treatment of chronic glomerulonephritis. Dimitrakov D, Kumchev E, Tzekov V, Manev E, Tzvetkova Z, Tilkyan E, Pandeva S, Nikolov D. Folia Med (Plovdiv); 1998 Feb; 40(2):67-73. PubMed ID: 9707816 [Abstract] [Full Text] [Related]
71. Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis. Allinovi M, Trivioli G, Lugli G, Villanti M, Gianassi I, Antognoli G, Romagnani P, Vaglio A, Caroti L, Cirami CL. Nephrol Dial Transplant; 2022 Mar 25; 37(4):789-791. PubMed ID: 34788862 [No Abstract] [Full Text] [Related]
72. Clinical and pathologic correlates in recurrently active childhood nephrosis. Schwartz MW, Hurwitz R, Cornfeld D. Am J Dis Child; 1970 Sep 25; 120(3):211-6. PubMed ID: 5458555 [No Abstract] [Full Text] [Related]
73. [Immunosuppressive therapy of primary focal sclerosing glomerulonephritis in the adult: a systematic review]. Quereda C, Ballarín J, Galeano C, García López F, Praga M. Nefrologia; 2007 Sep 25; 27(3):249-60. PubMed ID: 17725445 [No Abstract] [Full Text] [Related]
75. [Indices for vegetative maintenance of the organism of children with acute glomerulonephritis]. Umarov RKh. Lik Sprava; 2001 Dec 25; (3):48-51. PubMed ID: 11560026 [Abstract] [Full Text] [Related]
76. Cyclosporin and prednisolone: do they prevent recurrence of focal segmental glomerulosclerosis? Deray G. Nephron; 1987 Dec 25; 45(4):327. PubMed ID: 3587475 [No Abstract] [Full Text] [Related]
77. [The clinico-morphological characteristics and treatment of minimal-change glomerulonephritis and focal-segmental glomerulosclerosis-hyalinosis]. Diadyk AI, Vasilenko IV, Khomenko MV, Shpilevaia NI, Iarovaia NF, Malovichko IS. Lik Sprava; 1995 Dec 25; (9-12):75-8. PubMed ID: 8983800 [Abstract] [Full Text] [Related]
78. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis]. Klinger M, Szewczyk Z. Przegl Lek; 1989 Dec 25; 46(10):744-9. PubMed ID: 2687950 [No Abstract] [Full Text] [Related]
79. [Minimal-change glomerulonephritis and focal-segmental glomerulosclerosis-hyalinosis in adults]. Diadyk AI, Khomenko MV, Shpilevaia NI, Iarovaia NF, Malovichko IS. Lik Sprava; 1996 Dec 25; (5-6):32-6. PubMed ID: 9377396 [No Abstract] [Full Text] [Related]
80. [Glomerulonephritis with minimal changes and focal glomerulosclerosis in the adult. Analysis of 20 cases]. Martín R, Alvarez C, Roque H, Paz RA. Medicina (B Aires); 1978 Dec 25; 38(6 Pt 1):621-8. PubMed ID: 750853 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]